Showing results (201-210 of 377) with videos related to
Sort By:
Pageof 38
Journal of the National Cancer Institute|September 25, 2008
Hormone therapy and the risk of breast cancer in BRCA1 mutation carriersAndrea Eisen, Jan Lubinski, Jacek Gronwald, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 9, 2005
A comparison of bilateral breast cancers in BRCA carriersJeffrey N Weitzel, Mark Robson, Barbara Pasini, et al.Research Square|August 26, 2024
Pharmacokinetics and Pharmacogenomics of Ribociclib in Black Patients with Metastatic Breast Cancer: The LEANORA studySandra Swain, Ilana Schlam, D Max Smith, et al.Research Square|December 3, 2025
Longitudinal Quality of Life in Adults with Metastatic Breast Cancer: The Impact of Between- and Within- Person Changes in Symptoms and Positive AffectBrenna Mossman, Brent J Small, Elizabeth L Addington, et al.Journal of the National Cancer Institute|March 31, 2025
Development of a Multi-Institutional Dataset to Validate a Novel Inflammatory Breast Cancer Diagnostic ScoreFilipa Lynce, Samuel M Niman, Megumi Kai, et al.Public Health Genomics|February 5, 2025
Pediatric DTC Genetic Testing for Adult-Onset Inherited Cancer Risk: The Perspectives of High-Risk ParentsMadison K Kilbride, Beth N Peshkin, Jada G Hamilton, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 23, 2014
Randomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancerMarc D Schwartz, Heiddis B Valdimarsdottir, Beth N Peshkin, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2005
Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control studyAndrea Eisen, Jan Lubinski, Jan Klijn, et al.Journal of Genetic Counseling|October 13, 2015
Patient Perceptions of Telephone vs. In-Person BRCA1/BRCA2 Genetic CounselingBeth N Peshkin, Scott Kelly, Rachel H Nusbaum, et al.The Lancet. Oncology|April 19, 2014
Everolimus for women with trastuzumab-resistant, HER2-positive, advanced breast cancer (BOLERO-3): a randomised, double-blind, placebo-controlled phase 3 trialFabrice André, Ruth O'Regan, Mustafa Ozguroglu, et al.Pageof 38